-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Intracellular Complement and Adoptive Immunity

Program: General Sessions
Session: Presidential Symposium
Tuesday, December 12, 2023, 11:00 AM-12:30 PM

Claudia Kemper, PhD

NHLBI, NIH, Bethesda, MD

Disclosures: Kemper: Apellis Pharmaceuticals, Inc.: Other: An NIH approved CRADA (collaborative research project agreement)) .

See more of: Presidential Symposium
See more of: General Sessions
<< Previous Presentation | Next Presentation >>